These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6446261)

  • 1. Penetration of spectinomycin into cerebrospinal fluid duirng experimental meningitis.
    Delgado DG; Brau CJ; Avent CK
    Antimicrob Agents Chemother; 1980 Feb; 17(2):286-7. PubMed ID: 6446261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of meningitis and probenecid on the penetration of vancomycin into cerebrospinal fluid in rabbits.
    Krontz DP; Strausbaugh LJ
    Antimicrob Agents Chemother; 1980 Dec; 18(6):882-6. PubMed ID: 7235677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of cefamandole and ampicillin in experimental meningitis.
    Beaty HN; Walters E
    Antimicrob Agents Chemother; 1979 Nov; 16(5):584-8. PubMed ID: 525998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New cephalosporins cefotaxime, cefpimizole, BMY 28142, and HR 810 in experimental pneumococcal meningitis in rabbits.
    Täuber MG; Hackbarth CJ; Scott KG; Rusnak MG; Sande MA
    Antimicrob Agents Chemother; 1985 Mar; 27(3):340-2. PubMed ID: 3838872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trimethoprim-sulfamethoxazole vs. ampicillin in the treatment of experimental meningitis due to Streptococcus pneumoniae.
    Durack DT; Corey GR; Perfect JR
    Rev Infect Dis; 1982; 4(2):311-4. PubMed ID: 6981157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide concentrations and cerebrospinal fluid parameters in an experimental animal model of Streptococcus pneumoniae meningitis.
    Destache CJ; Pakiz CB; Dash AK; Larsen C
    Pharmacotherapy; 1998; 18(3):612-9. PubMed ID: 9620112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretreatment with granulocyte colony-stimulating factor attenuates the inflammatory response but not the bacterial load in cerebrospinal fluid during experimental pneumococcal meningitis in rabbits.
    Ostergaard C; Benfield T; Gesser B; Kharazmi A; Frimodt-Møller N; Espersen F; Lundgren JD
    Infect Immun; 1999 Jul; 67(7):3430-6. PubMed ID: 10377123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of methylprednisolone on entry of ampicillin and gentamicin into cerebrospinal fluid in experimental pneumococcal and Escherichia coli meningitis.
    Scheld WM; Brodeur JP
    Antimicrob Agents Chemother; 1983 Jan; 23(1):108-12. PubMed ID: 6338816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzyme immunoassay of the capsular polysaccharide of Streptococcus pneumoniae type III in cerebrospinal fluid in experimental meningitis.
    Nolan CM; Ulmer WC
    J Med Microbiol; 1980 Nov; 13(4):551-60. PubMed ID: 7001027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clarithromycin lacks bactericidal activity in cerebrospinal fluid in experimental pneumococcal meningitis.
    Schmidt T; Froula J; Täuber MG
    J Antimicrob Chemother; 1993 Oct; 32(4):627-32. PubMed ID: 8288505
    [No Abstract]   [Full Text] [Related]  

  • 11. Rosaramicin versus penicillin G in experimental Pneumococcal meningitis.
    Nolan CM; Monson TP; Ulmer WC
    Antimicrob Agents Chemother; 1979 Dec; 16(6):776-80. PubMed ID: 43705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of cephalothin and desacetylcephalothin in cerebrospinal fluid in therapy for experimental pneumococcal meningitis.
    Nolan CM; Ulmer WC
    J Infect Dis; 1980 Mar; 141(3):326-30. PubMed ID: 7365282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling of transfer kinetics at the serum-cerebrospinal fluid barrier in rabbits with experimental meningitis: application to grepafloxacin.
    Pfister M; Zhang L; Hammarlund-Udenaes M; Sheiner LB; Gerber CM; Täuber MG; Cottagnoud P
    Antimicrob Agents Chemother; 2003 Jan; 47(1):138-43. PubMed ID: 12499181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonsteroidal anti-inflammatory agents in the therapy for experimental pneumococcal meningitis.
    Tuomanen E; Hengstler B; Rich R; Bray MA; Zak O; Tomasz A
    J Infect Dis; 1987 May; 155(5):985-90. PubMed ID: 3470394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The postantibiotic effect in the treatment of experimental meningitis caused by Streptococcus pneumoniae in rabbits.
    Täuber MG; Zak O; Scheld WM; Hengstler B; Sande MA
    J Infect Dis; 1984 Apr; 149(4):575-83. PubMed ID: 6609999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of dexamethasone on efficacy of ceftriaxone and vancomycin therapy in experimental pneumococcal meningitis.
    Cabellos C; Martinez-Lacasa J; Martos A; Tubau F; Fernández A; Viladrich PF; Gudiol F
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2158-60. PubMed ID: 8540738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amino acids in cerebrospinal and brain interstitial fluid in experimental pneumococcal meningitis.
    Guerra-Romero L; Tureen JH; Fournier MA; Makrides V; Täuber MG
    Pediatr Res; 1993 May; 33(5):510-3. PubMed ID: 8099728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of fosfomycin in a rabbit model of experimental pneumococcal meningitis.
    Nau R; Zysk G; Reinert RR; Mergeryan H; Eiffert H; Prange HW
    J Antimicrob Chemother; 1995 Dec; 36(6):997-1004. PubMed ID: 8821598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental pneumococcal meningitis. IV. The effect of methyl prednisolone on meningeal inflammation.
    Nolan CM; McAllister CK; Walters E; Beaty HN
    J Lab Clin Med; 1978 Jun; 91(6):979-88. PubMed ID: 650062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and bacteriological efficacies of apalcillin and cefpiramide in experimental pneumococcal meningitis.
    Sato K; Shelton S; Nelson JD
    Antimicrob Agents Chemother; 1984 Oct; 26(4):578-9. PubMed ID: 6517548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.